← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$49K

Shares

1,681

Price

$29

Filed

Mar 3

Insider

Name

Milanova Tsveta / Jones Cecilia / Gheuens Sarah / Burns James William

Title

Chief Commercial Officer

CIK

0001957180

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

38,778

Footnotes

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025. | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. | The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments. | This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter. | The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. | The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Filing Info

Accession No.

0001439222-26-000036

Form Type

4

Issuer CIK

0001439222

Milanova Tsveta / Jones Cecilia / Gheuens Sarah / Burns James William's History

Date Ticker Type Value
2026-04-02 AGIO M $0
2026-04-02 AGIO $113K
2026-04-02 AGIO M $0
2026-03-02 AGIO M $0
2026-03-02 AGIO $49K
2026-03-02 AGIO M $0
2026-03-02 AGIO $34K
2026-03-02 AGIO M $0
2026-03-02 AGIO M $0
2026-03-01 AGIO A $0

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$1.2M 2026-04-02
Jones Cecilia
Chief Financial Officer
$172K 2026-04-02
Washburn Theodore James Jr.
Principal Accounting Officer
$217K 2026-03-03
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$148K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Milanova Tsveta / Jones Cecilia / Gheuens Sarah / Burns James William
Chief Commercial Officer
$34K 2026-03-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$185K 2026-04-02